Cortistatin as a pleiotropic regulator of neuroimmune and inflammatory pathways in experimental disease: a scoping review of preclinical evidence

Inflammopharmacology · Published 2026-07-01 · DOI 10.1007/s10787-026-02319-x

Free full text

Authors (6)

Marcelo Eduardo Cardozo, João Victor Cardoso dos Santos, Lilian Lacerda Bueno, Ricardo Toshio Fujiwara, Ana Laura Grossi de Oliveira, Cristiane Alves da Silva Menezes

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Cardozo, M., Santos, J., Bueno, L., et al. (2026). Cortistatin as a pleiotropic regulator of neuroimmune and inflammatory pathways in experimental disease: a scoping review of preclinical evidence. Inflammopharmacology. https://doi.org/10.1007/s10787-026-02319-x

Related articles

• REJENERA©, a multi-component bioflavonoid-based formula, alleviates osteoarthritis and provides chondroprotection by regulating the NLRP3-TXNIP-iNOS axis and inflammation: a comparative study with olive leaf nutraceuticals and ibuprofen · Inflammopharmacology · 2026 · Same journal
• Antioxidative and anti-inflammatory effects of monoterpene linalool in rats with letrozole-induced polycystic ovarian syndrome: modulation of autophagy and apoptosis · Inflammopharmacology · 2026 · Same journal
• Mangiferin in combination with primaquine reduces disease progression and transmission potential while alleviating cerebral pathology through suppression of neural cell apoptosis in experimental cerebral malaria · Inflammopharmacology · 2026 · Same journal
• Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis · Inflammopharmacology · 2026 · Same journal
• Regulation of NLRP3 inflammasome signaling in Alzheimer’s disease: emerging neuroprotective role of phytochemicals · Inflammopharmacology · 2026 · Same journal
• Agomelatine for Sjögren’s syndrome: a study on its therapeutic effects and mechanisms · Inflammopharmacology · 2026 · Same journal
• The lung–brain axis in neurodegeneration: inflammatory, immune, and vascular mechanisms with therapeutic implications · Inflammopharmacology · 2026 · Same journal
• Therapeutic and research frontiers in fibromyalgia: integrating pathophysiology with innovative drug repurposing · Inflammopharmacology · 2026 · Same journal
• Cytotoxic and computational profiling of 2-mercaptobenzimidazole Mannich derivatives: structure activity relationship and carbonic anhydrase binding assessment · Inflammopharmacology · 2026 · Same journal
• Anti-inflammatory evaluation of HPLC-GC quantified phytochemicals from Acalypha indica L. using LPS-induced inflammation model · Inflammopharmacology · 2026 · Same journal